We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
CERO

Price
10.68
Stock movement down
-0.82 (-7.13%)
Company name
CERo Therapeutics Holdings, Inc. Common Stock
Exchange
(NASDAQ
,
Currency
USD
)
Sector
Healthcare >
Biotechnology
Market cap
12.87M
Ent value
-
Price/Sales
-
Price/Book
-
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
-
Forward P/E
-
PEG
-
EPS growth
-
1 year return
-98.47%
3 year return
-91.90%
5 year return
-
10 year return
-
Last updated: 2025-08-27

DIVIDENDS

CERO does not pay dividends or no data was received

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E-
Price to OCF-
Price to FCF-
Price to EBITDA-
EV to EBITDA-

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales-
Price to Book-
EV to Sales-

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

FINANCIALS

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open11.27
Daily high11.52
Daily low9.60
Daily Volume938K
All-time high22640.00
1y analyst estimate45.00
Beta0.49
EPS (TTM)-
Dividend per share-
Ex-div date-
Next earnings date-

Downside potential

Loading...
Downside potential data
CEROS&P500
Current price drop from All-time high-99.95%-3.04%
Highest price drop-99.97%-56.47%
Date of highest drop16 Jun 20259 Mar 2009
Avg drop from high-36.89%-11.04%
Avg time to new high8 days12 days
Max time to new high346 days1805 days

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

COMPANY DETAILS
CERO (CERo Therapeutics Holdings, Inc. Common Stock) company logo
Marketcap
12.87M
Marketcap category
Small-cap
Description
CERo Therapeutics Holdings, Inc., an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead development candidate is CER-1236, an autologous T cell therapy candidate for the treatment of hematologic malignancies and solid tumors. The company was incorporated in 2021 and is based in South San Francisco, California.
Employees
8
Investor relations
-
SEC filings
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

UNDERSTAND THE BUSINESS
Loading...